Abstract: To determine the state of a subject person with a simple structure, an image determining device includes: an imaging unit that captures an image from a first direction, the image including the subject person; a first detector that detects size information from the image, the size information being about the subject person in the first direction; a second detector that detects position-related information, the position-related information being different from the information detected by the first detector; and a determining unit that determines the state of the subject person, based on a result of the detection performed by the first detector and a result of the detection performed by the second detector.

Abstract: A reflection unit 31 to 34 has an outer reflection panel 311 to 314 and an inner reflection panel 321 to 324. The outer reflection panel 311 to 314 is disposed around power generation units 22 to 24. The inner reflection panel 321 to 324 is disposed substantively parallel to the outer reflection panel 311 to 314 between the outer reflection panel 311 to 314 and the power generation units 22 to 24. The reflection units 31 to 34 reflects solar light injected into gaps 361 to 364 between the outer reflection panels 311 to 314 and the inner reflection panels 321 to 324 to transmit the solar light into the power generation units 22 to 24.

Abstract: The present invention herein provides a 2-pyridone derivative which has a cell adhesion-inhibitory activity and which is useful for preventing and/or treating pathema or disease conditions including, for instance, inflammations which relate to leukocytic infiltration. The 2-pyridone derivative is a compound represented by the following general formula (1). In the formula, R1 represents, for instance, a phenyl or pyridyl group, R2 represents, for instance, a phenyl group, R3 represents, for instance, a lower alkyl group, R4 represents, for instance, a lower alkyl group, R5 represents, for instance, a lower alkyl group, and R6 represents, for instance, a lower alkyl group.

Abstract: The present invention provides a 4-oxoquinolizine antibacterial agent having a 2-pyridone skeleton as a partial structure and also having a strong antibacterial effect on gram-positive bacteria, gram-negative bacteria or anaerobic bacteria. The compound having the following formula (I) or a pharmaceutically acceptable salt thereof: wherein: R1 represents hydrogen atom or a carboxyl-protecting group, R2 represents hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxyl group or hydroxyl group, R3 represents phenyl group or an aromatic substituent selected from the group consisting of 5-membered and 6-membered heterocyclic groups and R3 has a substituent selected from the group consisting of a hydrogen atom, a lower alkyl group, a lower alkoxyl group, a nitro group, a cyano group, an amino group, an acyl group, a carbamoyl group and a ureido group, and R4 represents a hydrogen atom or a halogen atom.

Abstract: The present invention provides an antifungal agent for topical use and remedy for athlete's foot that comprises a new combination of medicines and has a strong antifungal activity against both genus Trichophyton and genus Candida. The antifungal agent for topical use and remedy for athlete's foot contain amorolfine with butenafine or terbinafine.

Abstract: The present invention provides a 4-oxoquinolizine antibacterial agent having a 2-pyridone skeleton as a partial structure and also having a strong antibacterial effect on gram-positive bacteria, gram-negative bacteria or anaerobic bacteria.

Abstract: A compound represented by the following Formula (I) or a pharmaceutically acceptable salt thereof: wherein R1 represents a hydrogen atom or a carboxyl-protecting group, R2 represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group or a hydroxyl group, R3 represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a nitro group, a cyano group, a hydroxyl group or an amino group; R4 represents a hydrogen atom, an amino-protecting group, an alkyl group or a cycloalkyl group, and R5 represents a hydrogen atom, a halogen atom, an alkyl group, an alkenyl group, a cycloalkyl group, an aryl group, an alkoxy group, an alkylthio group, a hydroxyl group, an imino group or an amino group.

Abstract: A compound represented by the following Formula (I) or a pharmaceutically acceptable salt thereof: 1

Abstract: In a method of measuring the contamination profile of the inner surfaces of a radioactively contaminated pipe embedded within a concrete structure in a nuclear reactor facility, the detecting surface of a detector to be inserted into the contaminated pipe is fitted with a movable shield plate or cover, which is moved by a specified distance and the radioactive contamination profile within a limited area of the inner surfaces of the pipe is measured in terms of the difference in radiation intensity measured in two states, one where the shield plate or cover is in contact with the detecting surface and the other where it is spaced from the latter.